Lipid-modifying therapy in the elderly

Area of Science:

• Gerontology
• Cardiology
• Pharmacology

Background:

• Cardiovascular disease (CVD) mortality and morbidity rise with age due to cumulative exposure and risk factors.
• Hospitalization for CVD is substantially higher in the elderly (85+ years) compared to younger populations.
• Increasing life expectancy necessitates greater attention to lipid management in aging populations.

Purpose of the Study:

• To review the current knowledge on managing lipid disorders in elderly individuals.
• To address the challenges and controversies in lipid-lowering therapy for older adults.
• To propose evidence-based guidelines for lipid management in the elderly.

Main Methods:

• Comprehensive literature review of studies on lipid disorders and their management in the elderly.
• Analysis of data regarding CVD risk factors, treatment rates, and clinical trial evidence in older age groups.
• Synthesis of current knowledge to formulate management recommendations.

Main Results:

• Lipid management is indicated for a growing number of older adults, particularly for secondary prevention and primary prevention in those aged 65-75.
• Treatment rates for lipid-lowering drugs are significantly lower in the elderly, especially in the oldest groups (85+ years).
• Data from randomized trials for elderly populations are limited, leading to controversies and suboptimal treatment.

Conclusions:

• Effective lipid management in the elderly is complex, with insufficient evidence for optimal decision-making in many cases.
• There is a critical need for improved evidence and guidelines to ensure appropriate lipid-lowering therapy in older adults.
• This review provides a summary of current knowledge and proposes management strategies for lipid disorders in the elderly.